Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak

References

• Beauchesne PD, Bertrand S, Branche R, Linke SP, Revel R, Doré JF, Pedeux RM. 2003. Human malignant glioma cell lines are sensitive to low radiation doses. International Journal of Cancer 105:33–40.
   PubMed Web of Science ®Google Scholar
• Belli M, Bettega D, Calzolari P, Cera F, Cherubini R, Dalla Vecchia M, Durante M, Favaretto S, Gialanella G, Grossi G, Marchesini R, Moschini G, Piazzola A, Poli G, Pugliese M, Sapora O, Scampoli P, Simone G, Sorrentino E, Tabocchini MA, Tallone L, Tiveron P. 2000. Inactivation of human normal and tumour cells irradiated with low energy protons. International Journal of Radiation Biology 76:831–839.
   PubMed Web of Science ®Google Scholar
• Belli M, Cherubini R, Finotto S, Moschini G, Sapora O, Simone G, Tabocchini MA. 1989. RBE-LET relationship for the survival of V79 cells irradiated with low energy protons. International Journal of Radiation Biology 55:93–104.
   PubMed Web of Science ®Google Scholar
• Bettega D, Calzolari P, Chauvel P, Courdi A, Herault J, Iborra N, Marchesini R, Massariello P, Poli GL, Tallone L. 2000. Radiobiological studies on the 65 MeV therapeutic proton beam at Nice using human tumour cells. International Journal of Radiation Biology 76:1297–1303.
   PubMed Web of Science ®Google Scholar
• Cirrone GAP, Cuttone G., Lojacono PA, Lo Nigro S, Mongelli V, Patti V, Privitera G., Raffaele L, Rifuggiato D, Sabini MG, Salamone V, Spatola C, Valastro LM. 2004. A 62 MeV proton beam for the treatment of ocular melanoma at Laboratori Nazionali del Sud-INFN. IEEE Transactions on Nuclear Science 51:860–865.
   Web of Science ®Google Scholar
• Courdi A, Brassart N, Herault J, Chauvel P. 1994. The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protons. The British Journal of Radiology 67:800–804.
   PubMed Web of Science ®Google Scholar
• Courdi A, Caujolle J-P, Grange J-D, Diallo-Rosier L, Sahel J, Bacin F, Zur C, Gastaud P, Iborra-Brassart N, Herault J, Chauvel P. 1999. Results of proton therapy of uveal melanomas treated in Nice. International Journal of Radiation Oncology, Biology, Physics 45:5–11.
   PubMed Web of Science ®Google Scholar
• De Nardo L, Moro D, Colautti P, Conte V, Tornielli G, Cuttone G. 2004a. Microdosimetric investigation at the therapeutic proton beam facility of CATANA. Radiation Protection Dosimetry 110:681–686.
   PubMed Web of Science ®Google Scholar
• De Nardo L, Cesari V, Iborra N, Conte V, Colautti P, Hérault J, Tornielli G, Chauvel P. 2004b. Microdosimetric assessment of Nice therapeutic proton beam biological quality. Physica Medica 20:71–77.
   Web of Science ®Google Scholar
• Egger E, Schalenbourg A, Zografos L, Bercher L, Böehringer T, Chamot L, Goitein G. 2001. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. International Journal of Radiation Oncology, Biology, Physics 51:138–147.
   PubMed Web of Science ®Google Scholar
• Egger E, Zografos L, Schalenbourg A, Beati D, Böehringer T, Chamot L, Goitein G. 2003. Eye retention after proton beam radiotherapy for uveal melanoma. International Journal of Radiation Oncology, Biology, Physics 55:867–880.
   PubMed Web of Science ®Google Scholar
• GEANT4. 1998. GEANT4: Detector Description and Simulation Tool, CERN Program Library.
   Google Scholar
• Green LM, Murray DK, Tran DT, Bant AM, Kazarians G, Moyers MF, Nelson GA. 2001. Response of thyroid follicular cells to gamma irradiation compared to proton irradiation. I. Initial characterization of DNA damage, micronucleus formation, apoptosis cell survival, and cell cycle phase redistribution. Radiation Research 155:32–42.
   Google Scholar
• International Atomic Energy Agency (IAEA). 2000. IAEA Technical Report Series No. 398. Absorbed dose determination in external beam radiotherapy: An international code of practice for dosimetry based on standards of absorbed dose to water. Vienna: IAEA. pp 135–150.
   Google Scholar
• International Commission on Radiation Units (ICRU) Report 49. 1993. Stopping powers and ranges for protons and α particles. Bethesda, MD: ICRU.
   Google Scholar
• Janni JF. 1982. Proton range-energy tables, 1 KeV–10 GeV, Part 1. Atomic Data and Nuclear Data Tables 27:147–339.
   Google Scholar
• Joiner MC, Marples B, Johns H. 1993. The response of tissues to very low doses per fraction: A reflection of induced repair? Recent Results in Cancer Research 130:27–40.
   PubMedGoogle Scholar
• Jungnelius U, Ringborg U, Aamdal S, Mattsson J, Stierner U, Ingvar C, Malmström P, Andersson R, Karlsson M, Willman K, Wist E, Bjelkengren G, Westberg R. 1998. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial. European Journal of Cancer 34:1368–1374.
   PubMed Web of Science ®Google Scholar
• Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of National Academy of Sciences of the USA 89:7491–7495.
   PubMed Web of Science ®Google Scholar
• Kumala S, Niemiec P, Widel M, Hancock R, Rzeszowska-Wolny J. 2003. Apoptosis and clonogenic survival in three tumour cell lines exposed to gamma rays or chemical genotoxic agents. Cellular and Molecular Biology Letters 8:655–665.
   PubMed Web of Science ®Google Scholar
• Lambin P, Malaise EP, Joiner MC. 1996. Might intrinsic radioresistance of human tumor cells be induced by radiation. International Journal of Radiation Biology 69:279–290.
   PubMed Web of Science ®Google Scholar
• Loeffler JS, Smith AR, Suit HD. 1998. The potential role of proton beams in radiation oncology. Seminars in Oncology 24:686–695.
   Web of Science ®Google Scholar
• Marples B, Joiner MC. 1993. The response of Chinese hamster V79 cells to low radiation doses: Evidence of enhanced sensitivity of the whole cell population. Radiation Research 133:41–51.
   PubMed Web of Science ®Google Scholar
• Marples B, Joiner MC. 2000. Modification of survival by DNA repair modifiers: A probable explanation for the phenomenon of increased radioresistance. International Journal of Radiation Biology 76:305–312.
   PubMed Web of Science ®Google Scholar
• Marshall ES, Matthews JHL, Shaw JHF, Nixon J, Tumewu P, Finlay GJ, Holdaway KM, Baguley BC. 1994. Radiosensitivity of new and established human melanoma cell lines: Comparison of [3H]thymidine incorporation and soft agar clonogenic assays. European Journal of Cancer 30A:1370–1376.
   PubMed Web of Science ®Google Scholar
• Matsubara S, Ohara H, Hiraoka T, Koike S, Ando K, Yamaguchi H, Kuwabara Y, Hoshina M, Suzuki S. 1990. Chromosome aberration frequencies produced by a 70 MeV proton beam. Radiation Research 123:182–191.
   PubMed Web of Science ®Google Scholar
• McKay MJ, Kefford RF. 1995. The spectrum of in vitro rediosensitivity in four human melanoma cell lines is not accounted for by different induction or rejoining of DNA double strand breaks. International Journal of Radiation Oncology Biology Physics 31:345–352.
   PubMed Web of Science ®Google Scholar
• Mirzaie-Joniani H, Eriksson D, Sheikhovaezin A, Johansson A, Löfroth P-O, Johansson L, Stigbrand T. 2002. Apoptosis induced by low-dose and low-dose-rate radiation. Cancer 94:1210–1214.
   PubMed Web of Science ®Google Scholar
• Miyato Y, Ando K. 2004. Apoptosis of human melanoma cells by a combination of lonidamine and radiation. Journal of Radiation Research 45:189–194.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Schmitz Th. 1996. The influence of the beam modulation technique on dose and RBE in proton radiation therapy. Physics in Medicine and Biology 41:1649–1663.
   PubMed Web of Science ®Google Scholar
• Paganetti H. 1998. Calculation of the spatial variation of relative biological effectiveness in a therapeutic proton field for eye treatment. Physics in Medicine and Biology 43:2147–2157.
   PubMed Web of Science ®Google Scholar
• Paganetti H. 2002. Nuclear interactions in proton therapy: Dose and relative biological effect distributions originating from primary and secondary particles. Physics in Medicine and Biology 47:747–764.
   PubMed Web of Science ®Google Scholar
• Passagne I, Evrard A, Winum J-Y, Depeille P, Cuq P, Montero J-L, Cupissol D, Vian L. 2003. Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression. Journal of Pharmacology and Experimental Therapeutics 307:816–823.
   PubMed Web of Science ®Google Scholar
• Petrović I, Ristić-Fira A, Todorović D, Valastro L, Cirrone GAP, Cuttone G. 2006. Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beam. International Journal of Radiation Biology 82:251–265.
   PubMed Web of Science ®Google Scholar
• Ristić-Fira AM, Petrović IM, Korićanac LB, Valastro LM, Privitera G, Cuttone G. 2008. Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line. Physica Medica 24:187–195.
   PubMed Web of Science ®Google Scholar
• Robertson JB, Williams JR, Schmidt RA, Little JB, Flynn DF, Suit HD. 1975. Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer 35:1664–1677.
   PubMed Web of Science ®Google Scholar
• Rudoltz MS, Kao G, Blank KR, Muschel RJ, McKenna WG. 1996. Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology. Seminars in Radiation Oncology 6:284–294.
   PubMedGoogle Scholar
• Schorl C, Sedivy JM. 2007. Analysis of the cell cycle phases and progression in cultured mammalian cells. Methods 41:143–150.
   PubMed Web of Science ®Google Scholar
• Smalley KSM, Eisen TG. 2002. Differentiation of melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest. Melanoma Research 12:187–192.
   PubMed Web of Science ®Google Scholar
• Tang JT, Inoue T, Yamazaki H, Fukushima S, Fournier- Bidoz N, Koizumi M, Ozekj S, Hatanaka K. 1997. Comparison of radiobiological effective depths in 65 MeV modulated proton beams. British Journal of Cancer 76:220–225.
   PubMed Web of Science ®Google Scholar
• Tsoulou E, Baggio L, Cherubini R, Kalfas CA. 2001. Radiosensitivity of V79 cells after alpha particle radiation at low doses. Radiation Protection Dosimetry 99:237–240.
   Web of Science ®Google Scholar
• Wilson RR. 1946. Radiological use of fast protons. Radiology 47:487–491.
   PubMed Web of Science ®Google Scholar
• Wouters BG, Lam GKY, Oelfke U, Gardey K, Durand RE, Skarsgard LD. 1996. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using chinese hamster V79 cells and the high-precision cell sorter assay. Radiation Research 146:159–170.
   PubMed Web of Science ®Google Scholar